期刊文献+

代谢综合征与脑卒中类型、并发症及预后的关系 被引量:2

Relationship between metabolic syndrome and cerebral stroke type,complication and prognosis
下载PDF
导出
摘要 目的探讨代谢综合征与脑卒中类型、并发症及预后的关系。方法对568例有代谢综合征的脑卒中患者(代谢综合征组)及209例无代谢综合征的脑卒中患者(无代谢综合征组)的临床资料进行对比分析。结果代谢综合征组脑梗死比率(93.0%)显著高于无代谢综合征组(85.2%)(P<0.01);肺部感染(51.9%)、呼吸衰竭(27.3%)、心功能衰竭(28.0%)、肾功能衰竭(14.3%)等并发症的发生率及死亡率(25.0%)明显高于无代谢综合征组(19.1%、13.9%、14.8%、5.3%、12.9%)(均P<0.01);治疗的总有效率(64.1%)明显低于无代谢综合征组(74.6%)(P<0.01)。结论有代谢综合征的脑卒中患者以脑梗死多见,并发症发生率高,预后较差。 Objective To explore the relationship between metabolic syndrome(MS) and cerebral stroke type,complication and prognosis.Methods Clinical data of 568 cerebral stroke patients with MS(MS group) and 209 cerebral stroke patients without MS(no-MS group) were compared and analyzed.Results In MS group,the incidence of cerebral infarction was significantly higher(93.0%) than that in the no-MS group(85.2%)(P<0.01). The incidence of complication (the rate of pulmonary infection was 51.9%,respiratory failure was 2...
作者 刘颖 丁立东
出处 《临床神经病学杂志》 CAS 北大核心 2008年第6期448-449,共2页 Journal of Clinical Neurology
关键词 代谢综合征 脑卒中 metabolic syndrome cerebral stroke
  • 相关文献

参考文献4

二级参考文献47

  • 1宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:610
  • 2Weber AA, Przytulski B, Schanz A, et al. Towards a definition of aspirin resistance:a typological approach[J]. Platelets, 2002, 13:37.
  • 3Mehta J, Mehta P, Burger C, et al. Platelet aggregation studies in coronary artery disease[J]. Atherosclerosis, 1978,31:169.
  • 4Hurlen M, Seljeflot I, Arnesen H. The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction[J]. Scand Cardiovasc J,1998,32:233.
  • 5Helgason CM, Tortorice KL, Winkler SR, et al. Aspirin response and failure in cerebral infarction[J]. Stroke, 1993,24:345.
  • 6Eikelboom JW, Hirsh J, Weitz JI, et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events[J]. Circulation, 2002,105:1650.
  • 7Altmanl R, Luciardi HC, Muntaner J, et al. The antithrombotic profile of aspirin. Aspirin resistance, or simply failure[J]? Thromb J, 2004,2:1.
  • 8Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients[J]. Thromb Res,1993,71:397.
  • 9Pappas JM, Westengard JC, Bull BS. Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy[J]. Arch Pathol Lab Med,1994,118:801.
  • 10Macchi L, Christiaens L, Brabant S, et al. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate[J]. Thromb Res, 2002,107:45.

共引文献3090

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部